Guggenheim Capital’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $54.9K | Sell |
|
|||||
|
2024
Q4 | $99.7K | Sell |
|
|||||
|
2024
Q3 | $123K | Sell |
|
|||||
|
2024
Q2 | $260K | Sell |
|
|||||
|
2024
Q1 | $853K | Buy |
|
|||||
|
2023
Q4 | $1.92M | Buy |
|
|||||
|
2023
Q3 | $1.27M | Sell |
|
|||||
|
2023
Q2 | $3.03M | Sell |
|
|||||
|
2023
Q1 | $3.05M | Sell |
|
|||||
|
2022
Q4 | $2.3M | Sell |
|
|||||
|
2022
Q3 | $1.84M | Sell |
|
|||||
|
2022
Q2 | $1.43M | Sell |
|
|||||
|
2022
Q1 | $4.1M | Buy |
|
|||||
|
2021
Q4 | $8.57M | Buy |
|
|||||
|
2021
Q3 | $8.63M | Buy |
|
|||||
|
2021
Q2 | $221K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $73K | Sell |
|
|||||
|
2019
Q2 | $194K | Buy |
|
|||||
|
2019
Q1 | $231K | Buy |
|